Related Experiment Video

Updated: Mar 2, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

12.1K

Improving the pharmacokinetics and tissue distribution of pyrinezolid by self-assembled polymeric micelles

Haiyue Long1, Xiaoling Li1, Zitai Sang1

  • 1State Key Laboratory of Biotherapy and Cancer Center, and Department of Neurosurgery, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, PR China.

Colloids and Surfaces. B, Biointerfaces
|May 21, 2017
PubMed

Insights

Novel pyrinezolid micelles (PZ-M) improve drug delivery for antibiotic-resistant bacteria. These micelles enhance oral bioavailability and lung exposure, offering a promising strategy against infections like MRSA pneumonia while reducing potential organ toxicity.

Area of Science:

  • Pharmacology and Drug Development
  • Biomaterials Science
  • Infectious Diseases

Background:

  • Antibiotic resistance is a critical global health challenge, necessitating novel antimicrobial agents.
  • Pyrinezolid (PZ), an oxazolidinone, shows efficacy against Gram-positive bacteria, including MRSA and VRE.
  • Poor water solubility limits the therapeutic potential of free Pyrinezolid.

Purpose of the Study:

  • To develop and characterize pyrinezolid micelles (PZ-M) using mPEG-PLLA copolymer to improve PZ solubility and delivery.
  • To evaluate the pharmacokinetic properties, tissue distribution, efficacy, and toxicity of PZ-M in vivo.
  • To assess the potential of PZ-M for treating MRSA-related pneumonia and mitigating drug-induced toxicities.

Main Methods:

  • Preparation of pyrinezolid micelles (PZ-M) via amphipathic mPEG-PLLA copolymer encapsulation.
  • In vivo pharmacokinetic studies to assess blood circulation time and oral bioavailability.
  • Tissue distribution analysis to determine drug exposure in lungs, liver, and kidneys.
  • In vivo efficacy and toxicity assessments in relevant models.

Main Results:

  • PZ-M exhibited significantly prolonged blood circulation time compared to free PZ.
  • Oral bioavailability of PZ was substantially increased when formulated as PZ-M.
  • PZ-M demonstrated enhanced drug exposure in the lungs while reducing accumulation in the liver and kidneys.
  • Preliminary toxicity profiles suggest a favorable safety margin for PZ-M.

Conclusions:

  • Pyrinezolid micelles (PZ-M) represent a viable formulation strategy to overcome the poor solubility of Pyrinezolid.
  • PZ-M enhance the pharmacokinetic profile of Pyrinezolid, improving oral delivery and targeted lung exposure.
  • This formulation holds promise for more effective treatment of Gram-positive bacterial infections, particularly MRSA pneumonia, with reduced systemic toxicity.
Keywords:
MicellePharmacokineticsPyrinezolidTissue distributionmPEG-PLLA

More Related Videos

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

9.3K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.6K

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
63
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
284
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
290
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
365
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
291
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51